Natixis Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-413,417
| Closed | -$4.13M | – | 1548 |
|
|
2023
Q3 | $4.13M | Buy |
413,417
+25,743
| +7% | +$257K | 0.01% | 772 |
|
|
2023
Q2 | $4.82M | Sell |
387,674
-252,758
| -39% | -$3.14M | 0.01% | 715 |
|
|
2023
Q1 | $8.97M | Buy |
640,432
+169,287
| +36% | +$2.37M | 0.03% | 528 |
|
|
2022
Q4 | $6.74M | Buy |
471,145
+70,364
| +18% | +$1.01M | 0.03% | 596 |
|
|
2022
Q3 | $10.2M | Sell |
400,781
-24,598
| -6% | -$628K | 0.04% | 427 |
|
|
2022
Q2 | $12.1M | Buy |
425,379
+128,150
| +43% | +$3.64M | 0.05% | 392 |
|
|
2022
Q1 | $10.5M | Buy |
297,229
+158,299
| +114% | +$5.58M | 0.04% | 444 |
|
|
2021
Q4 | $5.82M | Sell |
138,930
-2,470
| -2% | -$103K | 0.02% | 617 |
|
|
2021
Q3 | $6.94M | Buy |
141,400
+3,716
| +3% | +$182K | 0.03% | 527 |
|
|
2021
Q2 | $5.75M | Buy |
137,684
+33,894
| +33% | +$1.41M | 0.03% | 588 |
|
|
2021
Q1 | $3.7M | Buy |
103,790
+41,976
| +68% | +$1.5M | 0.02% | 692 |
|
|
2020
Q4 | $1.73M | Buy |
+61,814
| New | +$1.73M | 0.01% | 875 |
|